Aquafin CRC - Atlantic Salmon Aquaculture Subprogram: use of immunomodulation to improve fish performance in Australian temperate water finfish aquaculture
Strategic plan
This proposal is part of FRDC Industry Development Program, Strategy - Aquaculture development - production and production systems. However, it also has strong capacity building elements, including training of at least one PhD student in the area of fish health/immunology and providing workshops for industry and researchers (Use of immunostimulants in finfish culture, Immune response in fish). It provides leadership development by having a full time young researcher (CI - Dr Richard Morrison) working on this project. Thus, this proposal will significantly contribute to Human Capital Development Program, Leadership and Vocational Development. Improved knowledge of immune response and immunomodulators was identified as one of the key research areas for aquatic animal health in Research and Development Plan Aquatic Animal Health Subprogram. Priorities covered by this key research area included immunology in aquatic vertebrates (nature of disease and host-pathogen interactions), immunomodulators (aquatic animal health management) and development of tools for immune status monitoring as a means of implementing health management strategies (surveillance and monitoring). All three elements are included in this proposal. This proposal is consistent with R&D plans for Atlantic Salmon Aquaculture Subprogram and with Aquafin CRC AGD research program. It also addresses targeted priority: fish health, within Program 2: Industry Development, Key R&D issues for fisheries and aquaculture in SA, South Australia's Fisheries and Aquaculutre Research and Development Strategy 2002-2007. The research focus is within Tasmanian Fisheries and Aquaculture, Aquaculture Strategic Research Plan 1999-2004. This proposal fits well into Aquafin CRC strategy and mission by significant contribution of its outcomes to achieving sustainable aquaculture in Australia through reduction of economic impact of diseases in farmed fish, development of environmentally friendly approaches to disease management and training aquaculture industry and researchers in the fields of fish immunology.
Need for research
It is impossible to prevent the presence of pathogens in aquaculture systems, particularly in sea-cage grow-out. Most disease outbreaks occur when there is an interaction between pathogens and susceptible fish (for example immunocompromised fish due to stress). This will result in lowering the performance of the fish and possibly mortalities. Sustainable aquaculture of finfish requires lowering the risk of disease outbreaks and replacing disease treatment with control strategies. The use of immunomodulators is essential to achieve these goals, in particular in times of increased disease risk or reduced immunocompetence. Our understanding of host-pathogen interactions and immune response allows for the use of appropriate immunomodulators. For example, if a disease is caused by overreaction of the inflammatory response, traditional immunostimulants will not improve the outcomes. Similarly, there is a need to determine correct timing and dose for immunomodulation in mariculture. Improved immune response would improve fish performance during grow-out.
Importantly immunomodulators are natural products that are derived from microbes, thus avoiding the use of chemical products. Commerical immunomodulators have been successfully used in aquaculture worldwide however only experimentally in Australia. For example oral immunomodulators MicroVital significantly increases survival rates of Atlantic salmon following Vibrosis challenge and 32% gain in survival rates of salmon fed natural immunomodulators (ß glucans and nucleotides) following exposure to IPN (exotic viral disease) challenge has been achieved in trials in Norway. However, there is little information available for fish species other than salmon or diseases other than commercially important in Northern Hemisphere. There is a need to develop immunomodulation strategies that are directly applicable to Australian mariculture, either specific for our species or diseases affecting Australian aquaculture industry (for example Amoebic Gill Disease) or unique conditions such as water temperatures.
Benefits
For Atlantic salmon we will address AGD management by investigation of immunomodulators. AGD is the main health problem for salmon industry and successful use of immunomodulation could provide an answer, particularly in combination with other management strategies.
This project is generic and the benefits are not limited to the species we will use as a model in our investigation. Other finfish aquaculture industries will also benefit from training and workshops provided by this project.
Final report
Before this project our knowledge of immune response in Amoebic Gill Disease (AGD) was fundamentally limited and more information was required to assess the potential for immunomodulators in the management of AGD.
We confirmed that injection of bacterial DNA motif (CpG oligonucleotides) six days before AGD challenge can offer signficant protection to Atlantic salmon (relative percent survival up to 52.5%). However, there was no effect if the fish were challenged immediately post injection with bacterial DNA. This suggests that while there is a potential benefit from the use of immunostimulants, their application is limited because their efficacy is directly linked to the timing of an outbreak, which can be unpredictable in the field. While fish which survived an initial AGD episode show increased resistance to subsequent AGD infection, in contrast to some diseases this effect cannot be simply explained by the presence of antibodies. The duration of exposure (or number of exposures) appears to be important for the development of serum antibodies. Mucus antibodies could not be detected in Atlantic salmon that survived AGD challenge. Microarray experiments and further gene expression studies suggested that there is a loss of cell-cycle control in AGD lesions. Furthermore, immune pathways are affected since the down-stream effect(s) of the initial inflammatory signals were not detectable. It is possible that this significantly contributes to the extremely high rate of mortality in unmitigated AGD epizootics.
While we have achieved our objectives and answered many of the original questions, new issues have emerged from our research. These include a lack of understanding of the mechanisms of inhibition of inflammatory and immune pathways, significance of antibody response (if any) in AGD, and the potential for vaccine antigen discovery through the use of anti-peptide antibody. The presence and role of a more localised antibody response in the gill mucus or epithelium (currently undetectable) warrants further investigation.
In conclusion, we now have a better understanding of AGD pathogenesis and the reasons why the host immune response is ineffective in this disease. In particular, we have shown that immune pathways are inhibited in Atlantic salmon affected by AGD.
Keywords: Amoebic Gill Disease, salmon, aquaculture, immunostimulants, inflamation, gene expression, transcriptome analysis.
Aquaculture Nutrition Subprogram: evaluation of value-added grain protein products for Atlantic salmon and black tiger prawns
The need to reduce reliance of aquaculture industries on fish based protein resources has long been recognized as an important issue. Notably the Fisheries Research and Development Corporation have given this issue such importance it is rated among their 9 key challenges to address in the 2000 – 2005 Research and Development Plan. Substantial work has already been undertaken to address this challenge over the past 10 years. Notably, recent developments have seen the increased adoption of some grain based alternatives being used by the aquaculture feed manufacturing industries. Lupin kernel meal use by this sector in particular is a prominent success story.
As the aquaculture feed industries begin to increase their use of alternative protein resources, such as lupin kernel meals, it becomes increasingly important to develop quality assurance (QA) assessment criteria for specific feed ingredients. The nature of these criteria will vary depending on the end use of the product. An improved understanding of the nutritional value and functional properties of the ingredients is also required to maximize the use of these ingredients by these industries and to begin the QA criteria development process.
Presently the extruded fin-fish feed sector (primarily salmonid feeds) is the largest aquaculture user of value-added grain products in Australia. However, it is apparent that further development of market confidence, through resolution of some of the nutritional value assessment and processing issues, is required for some additional aquaculture sectors (e.g. prawns) to encourage routine use of these products and work addressing these issues is planned in this proposal.
Furthermore, exploration of new product possibilities has already begun in the GRDC project with the development of a series of very promising lupin protein concentrates. However, further evaluation of the potential and constraints for the use of these new and innovative products within aquaculture feeds is needed and additional evaluation in Atlantic salmon and prawns is required.
Final report
This program represents a major collaborative initiative between the Grains and Fisheries Research and Development Corporations. It has engaged seven different research providers and three industrial collaborators in achieving its outcomes. Numerous findings were encountered through this program, which are collated in this report.
Key among those findings is:
- The dehulling of lupins significantly improves their nutritional value to fish. A linear increase in digestible energy value was observed, while a curvilinear response in digestible protein value was observed. This finding shows that there is significant nutritional benefit to the fish in optimizing the dehulling efficiency of lupins, but in terms of protein value that a minor contamination with hulls is unlikely to significantly reduce the protein value.
- Considerable variability in the digestible protein and energy value of the lupin kernel meals was observed. It was shown that this variability could be assessed as a function of grain composition.
- Considerable variability in the composition of lupin kernel meals was observed among the 76 samples evaluated for digestibility. As protein increased in each lupin kernel meal a reciprocal decrease in NSP was observed.
Aquafin CRC - Atlantic Salmon Aquaculture Subprogram: development of an AGD vaccine: phase II
Aquafin CRC - Atlantic Salmon Aquaculture Subprogram: establishment of challenge for AGD
Strategic plan
This proposal is part of the FRDC Industry Development Program, Strategy – Aquaculture Development – Production and Production Systems. The project includes a technician and a postdoctoral research fellow (Dr Philip Crosbie) as co-investigator and they will both be provided with suitable professional development opportunities through the Education Program of the Aquafin CRC. Later in the project it may be possible to adopt a PhD student with an independent scholarship or include Honours and Masters projects as they are required and become available. Thus, the project will contribute to the Human Capital Development Program, Leadership and Vocational Development. This proposal includes several key research areas outlined in the Aquatic Animal Health Subprogram Strategic R&D Plan, namely the Nature of disease and host-pathogen interactions and Training and capacity building. Relevant priorities being: to provide improved knowledge of the biology of disease agents (in this case the AGD-causing organism), and an improved knowledge of host responses to disease agents which will be partially addressed by monitoring the specific antibody response to N. pemaquidensis antigens (Nature of disease and host-pathogen interactions). Both the research and service components of this proposal will expand the technical skill base in aquatic animal health and facilitate R&D knowledge transfer (Training and capacity building). This project will underpin other projects that contribute to the Aquafin CRC Health Program Outcomes ie. reduced economic impact of disease (AGD) in finfish (Atlantic salmon) farming.
Need for this research
The continued existence of Atlantic salmon farming in Tasmania is threatened by AGD. Production is expected to increase over the next few years and this will undoubtedly lead to an increase in the incidence of AGD. The AGD control method of freshwater bathing has increased in frequency with the growth in production over the past few years and this trend is expected to continue. This will present a growing cost burden to salmon growers, it is therefore imperative that the impact of AGD on the industry be reduced so as to maintain viability for the future. Multidisciplinary teams have been assembled to achieve this outcome via a number of projects. The projects are complementary and in some cases interdependent where progress in one area is dependent on progress in another area. This is particularly the case with the service component of the current proposal and the vaccine development program, where supply of infective material and a means of controlled testing of candidate vaccines are integral to success. Vaccine development requires identification of specific antigens from the pathogen that will elicit a protective immune response in the host, hence the need for significant quantities of infective material. Similarly, success of the treatment of AGD investigation is dependent on supply of cells for initial screening of a battery of potential therapeutants in vitro before attempting field trials. The research component of the proposal, which is the development of a standard AGD challenge method that can be used in experimental tanks, is essential for the success of these projects. We need to be able to consistently induce AGD in fish to economically appraise alternative treatments and candidate vaccines before moving onto costly field trials. Inducing experimental infections is widely recognised as one of the cornerstones of vaccine development (Nordmo, 1996).
Benefits
The major benefit will be enabling progress in the vaccine development and alternative treatment projects to be made. We will have in place a model to economically appraise novel treatments, experimental vaccines and other less specific means of prophylaxis such as immunomodulation. Ultimately the project will contribute to a collective outcome of lessening the impact of AGD on salmon producers and reducing the estimated 10-20% of production costs that is currently spent controlling the disease. Other benefits include a better understanding of risk factors contributing to AGD, and the opportunity to investigate the virulence mechanisms of the organism. Overall the project will contribute to research output and service. The systematic development and subsequent use of challenge models will yield publishable material. The service aspect will be in the supply of amoebae to collaborators and provision of a means to test novel therapeutants, experimental vaccines and immunomodulatory compounds.
References
Nordmo, R., 1996. Strengths and Weaknesses of Different Challenge Methods. In: Fish Vaccinology (ed. By Gudding, R., Lillehaug, A., Midtlyng, P.J. and Brown, F.) Developments in Biological Standardisation. Basel, Karger p 303-309
Final report
This project has increased our knowledge of Amoebic Gill Disease, in particular about the pathogen and the dynamics of infection. We have described a new species of neoparamoeba, Neoparamoeba perurans, and showed that it has been consistently associated with AGD worldwide. Stocking density, acclimation to sea water and amoeba batch variability affected AGD infections. During this project challenge protocols were developed, which have been successfully used and their results correlated well with field challenge. This project provided crucial support for all AGD research through provision of amoebae and salmon for all AGD projects and running experimental challenges for trial vaccines.
The main objectives of this project were to provide essential service for AGD research. During this project we standardised existing AGD challenge protocol and developed a new in vivo gill attachment challenge assay. Both challenge protocols have been successfully applied in AGD research. Research on virulent amoebae resulted in a description of a new species, which consequently has been shown to be involved in all AGD cases worldwide. This discovery led to the development of new diagnostic tests, which are now available for confirmation of AGD infections and further research.
In conclusion, this project has not only provided essential support for all AGD research by supplying amoebae and salmon and running AGD challenges for the experimental vaccines, but also increased our knowledge and understanding of AGD.
Keywords: Amoebic Gill Disease, salmon, aquaculture.
Aquafin CRC - Atlantic Salmon Aquaculture Subprogram: commercial AGD and salmon health project
There is an urgent need to develop and commercialise treatments for the control of amoebic gill disease in the Atlantic salmon aquaculture industry in Tasmania. The cost-benefit analysis undertaken by the Aquafin CRC suggested a net present value of economic benefit of $21.6M AUD and a benefit/cost ratio of 5.3. The need for short term (even interim) solutions for the control of AGD is paramount.
This project complements and continues the advances made by previous research (FRDC 2000/266 and 2001/205) that identified potential treatments. The current project will investigate commercial feasibility of treatments previously identified while providing an opportunity for examining new potential AGD treatments at the behest of the salmon aquaculture industry. Industry representatives, in a recent meeting, (January 15, 2004 Marine Research Laboratories, Taroona TAS) iterated the need for a flexible program that would allow potential treatments and control measures to be tested in the laboratory as well as in the field. This proposal (with budgetary constraints) has been developed to provide that flexibility with clearly identified treatments that will be investigated in the first instance. The road to commercialisation of any disease control treatment is a long and complex one, this project is designed to provide the information that may lead to a change of commercial practice in the control of AGD.
A program for the development and commercialisation of disease treatments is grounded in the identification of potential treatments that are tested both in vitro and in vivo in the laboratory. Once suitable laboratory testing is complete, then small-scale field trials are required and finally the scaling up of trials for commercialisation. A program for treatment develop must operate over a minimum of a 3 year funding cycle to maximise the likelihood of success maximising the productivity and contributions of all staff (Research leaders, technicians, post-doctoral fellows and graduate students). Through this approach, the outcomes of the research can be achieved, providing tangible solutions for industry, the acquisition of knowledge and intellectual property for the CRC and the training of quality personnel (Post-docs and PhD students).
Final report
Prior to this project there had been investigations into some potential candidate amoebicides, with little success except for the possibility of oxidative disinfectants such as chloramine-T. This project has since tested a number of amoebicides using a progressive approach of in vitro toxicity, in vivo efficacy in the laboratory through to in vivo efficacy under field conditions in either semi-commercial or under full commercialised field trials.
Although the practical delivery of some of these as treatments of amoebic gill disease (AGD), such as chloramine-T bathing, appear not to be practicable, other avenues may have potential for further commercial development, such as the dietary inclusion of potential amoebicidal compounds, including bithionol and ionophore-based amoebicides. The project has explored the potential of bithionol, a registered amoebicidal drug, as an in-feed treatment, showing that AGD severity can be reduced by approximately 50%. Similarly, the project has examined the efficacy of an immunostimulant-based feed additive, Aquacite and Betabec which reduced mortality in Atlantic salmon with AGD but did not affect the intensity of infection.
This project has further characterised the effects of gill disease, in particular AGD, with respect to the metabolic cost of disease to the fish. This work has estimated that in excess of 17% of the ingested energy is likely to go to service the cost of AGD. This approach provides a useful tool to incorporate into bioeconomic models for assessing the efficacy of AGD treatments in the future.
Keywords: Amoebic gill disease, Atlantic salmon, disease treatment.
Aquafin CRC - Atlantic Salmon Aquaculture Subprogram: molecular assessment of resistance to AGD in Atlantic salmon
Management costs (ca. 10% GVP) associated with AGD are severely limiting further expansion and sustainability of the Tasmanian Atlantic salmon industry. A holistic approach that combines alternative treatments, better management procedures, the use of a vaccine and selection of stock that are more resistant to infection would greatly reduce the impact of AGD. With the exception of selection the other areas are all active components of the Aquafin CRC Health Program. A more resistant stock along with even a partially effective treatment and vaccine would be of major benefit to the long-term sustainability of the industry.
An international consultant recommended to the industry and State Government in March 2003 that a selective breeding program should be established as soon as practical. A business plan for such a program has been developed and is under consideration by the industry. A major trait for inclusion in the program was resistance to AGD. Research in relation to understanding AGD resistance for use in selective breeding was ranked second to oral treatments in an industry survey of AGD priorities in June 2003.
Selection for resistance to external parasites in breeding programs is relatively novel and AGD is an issue specific to the Tasmanian industry, therefore unlike most other production traits in a breeding program reliance on overseas research and experience is impossible. With recent advances in molecular technologies it is now possible to investigate and understand variation to disease at the genetic level. Such knowledge on AGD will allow both improved understanding of the phenotypic variation (that will benefit other research areas) and identification of specific genetic markers that would allow faster genetic gains in resistance to be made in a selection program than would be possible via standard phenotypic selection alone.
Final report
The outcome of this project is the development, at the request of industry, of a proposal to enhance the genetic gains in the industry selective breeding program for AGD resistance through marker assisted selection. The confidence to proceed with such a proposal is brought about by the extensive knowledge and understanding gained on the molecular basis of AGD resistance through this project.
The project completed the first comparison of genetic variation at a coding gene between the domesticated Australian Atlantic salmon and their ancestral Canadian population; results were also compared to that published for European populations.
In contrast to previously reported variation at non-coding microsatellite loci, a high level of variation at the major histocompatibility (MH) genes was observed within the domesticated Australian population, and observed sequence diversity exceeded that reported for other cultured Atlantic salmon populations.
The project also completed the first study to examine resistance to AGD at a molecular level. The association between MH polymorphism and severity of AGD infection was examined in 30 full-sibling families by acute challenge.
Keywords: Atlantic salmon, Salmo salar, amoebic gill disease, AGD, Neoparamoeba, resistance, gene expression, DNA microarray.
Aquafin CRC - Atlantic Salmon Aquaculture Subprogram: effects of husbandry on AGD
Strategic plan
This proposal is fulfilling objectives of Aquafin CRC Centre Agreement and it is within the key research areas for Aquatic Animal Health Subprogram Strategic R&D Plan.
Aquafin CRC Centre Agreement:
This proposal fulfils the objective to reduce economic impact of disease in finifish farming (Program 3 Health) and provide environmentally friendly approaches to disease management (Program 3 Health). It falls within Subprogram 3B Management and control of Amoebic Gill Disease of Atlantic salmon.
Aquatic Animal Health Subprogram Strategic R&D Plan:
- aquatic animal health management
This proposal will establish AGD management on the farm
- best practice
Results of this project will contribute to the development of Regional Codes of Best Practice for Health, which is one of the priorities in the R&D Plan
- nature of disease and host-pathogen interaction (improved knowledge of the host-response to disease agent)
Parasitic protozoans are one of the priority groups for this key research area. This proposal also will contribute to evaluation of host-pathogen ineractions for intractable diseaess and identify risk factors to develop disease minimisation risk.
- training and capacity building (human capital development)
This proposal will provide training for one postdoctoral fellow and contribute to consolidation of knowledge and capability for parasitology of aquatic animals, which is one of the priorities
Need for research
There is a clear need to broaden the almost exclusive approach of managing AGD by treatment only. Identification of husbandry practices that lower disease incidence will be of immense value in curtailing the currently excessive costs of treatment. Understanding the reasons for reduced disease incidence within different salmon sub- populations at the farm level will have numerous flow of benefits to other AGD related research. In the recent AGD research survey of Tasmanian salmon producers it was stated that:
”Section role of farm management still needs some work particularly in the area of mature fish and lights. Farm observations show mature and lit fish being susceptible to infection and triploid fish having an apparent resistance to infection. We feel that study of the mechanisms involved in these examples should lead to a better understanding of the host-pathogen interaction”.
Disease outbreaks are a function of the interaction between host, pathogen and their environment. Under culture conditions it is impossible to prevent interaction between a pathogen and its host; however, the proposed study presents an opportunity to gain further knowledge, which can directly influence current industry approaches, regarding the effects of manipulating the host and its environment.
Benefits
Investigation of infection in relation to these different production strategies; ie, artificial lighting, triploids and maturation will improve management of AGD and lead to reducing AGD impact on the industry. This project will provide industry with a more detailed appraisal of AGD in the field, over a longer time period, incorporating multiple treatments and seasonal changes. The advent of enhanced understanding of AGD provided by this project will provide salmon industry with alternative, environmentally friendly strategies to lower production costs of which AGD mitigation is a significant part.
Final report
Before this project our knowledge of the effects of husbandry on Amoebic Gill Disease (AGD) was limited. This project allowed on-farm assessment of effects of husbandry procedures and stock characteristics on AGD severity. Furthermore, we investigated the potential to re-use fresh water for more than one bath. Preliminary results were promising. Further trials, including some on a larger scale should be undertaken to confirm that re-use of freshwater bath has a commercial potential.
Out of season smolt subjected to artificial lighting regimes and transferred to estuarine sites, where a marked halocline is present, required earlier bathing than fish from cages where no artificial lighting was used. However the advantage of fish subjected to artificial lighting not maturing would outweigh the disadvantage of the need for an earlier bath. This is because maturing fish were more affected by AGD than non-maturing fish. Neither supplemental oxygenation nor high-energy diet affected AGD. There was no statistically significant difference between males and females with regard to AGD. There was no evidence that ploidy had an effect on AGD, however the trial was compromised by the priorities of commercial farm management. There was no significant effect of gill damage on the severity of Amoebic Gill Disease.
In conclusion, this project has not only increased our understanding of the effects of husbandry on AGD but also has enhanced our ability to investigate AGD in the future. This will ultimately lead to direct benefits for the salmon industry.
Keywords: Amoebic Gill Disease, salmon, aquaculture, freshwater bathing
TSGA IPA: Understanding Dorvilleid ecology in Macquarie Harbour and their response to organic enrichment
Previous research has shown a clear impact gradient associated with cage salmon farming operations, and that presence of bacterial mats (Beggiatoa) and proliferation of opportunistic species are features commonly associated with high levels of organic enrichment (e.g. Pearson & Rosenberg, 1978). The presence of opportunists, such as Capitellid worms, being classified as representative of “unacceptable impact” (Macleod et al., 2004). This premise has been validated in SE Tasmania and underpins regulatory monitoring requirements statewide (DPIPWE, 2004).
The understanding that proliferation of opportunists represents deteriorating conditions was translated to monitoring protocols in Macquarie Harbour, but the relationship between opportunists and the level of enrichment was not explicitly tested in this region. However, video surveys suggest that in Dorvilleid worms rather than Capitellids were the species most indicative of organic enrichment effects(DPIPWE, 2004). Dorvilleids can tolerate anaerobic sediments and high levels of hydrogen sulphide (Levin et al. 2013) and are known to be indicators of the impacts of finfish aquaculture (e.g. Paxton et al. 2010).
However, Macquarie Harbour is ecologically very different to other farming areas in SE Tasmania; the sediments are inherently depauperate, largely epibiotic and spatially patchy. A recent study in Canada has highlighted the need to better understand the relationships and compliance thresholds for established enrichment indicators (i.e. Beggiatoa sp and opportunistic polychaete complexes) in systems where ecological patchiness may occur (Hamoutene et al 2014); suggesting that, where there is significant potential for small scale spatial variability, normal successional responses may not be as reliable. Consequently, the responses may not be consistent with expectations developed from southern Tasmanian regions.
In this context it is important to identify the relationship between Dorvilleids and sediment condition; determining the reliability of this species as an indicator of sediment condition, and characterising the environmental conditions associated with changes in Dorvilleid abundance.